Diagnosis and Treatment of Polycystic Ovary Syndrome

Polycystic ovary syndrome is the common endocrinopathy among reproductive-aged females in the all over the world, affecting approximately 6% of female patients. The pathophysiology of the disease is complex and there is no single defect from which it is known to result, it is hypothesized that insulin resistance is a key factors from asymptomatic to having multiple gynecologic, dermatologic, or metabolic manifestations. Advices from the Endocrine Society mentioned using the Rotterdam criteria for diagnosis, which mandate the presence of two of the following three findings—hyperandrogenism, ovulatory dysfunction, and polycystic ovaries and plus the exclusion of other diagnoses that could result in ovulatory dysfunction.

 

    Related Conference of Diagnosis and Treatment of Polycystic Ovary Syndrome

    March 24-25, 2020

    International Meeting on Reproductive Medicine and Womens Health

    Amsterdam | Netherlands
    July 17-18, 2020

    2nd World Conference on Breast and Cervical Cancer

    Helsinki, Finland
    October 19-20, 2020

    World Congress on Gynecology and Obstetrics

    Tokyo, Japan

    Diagnosis and Treatment of Polycystic Ovary Syndrome Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in